• Avandia®
• Avandia® Death Risk
• Avandia® Heart Attack
• Avandia® Pph
• Congestive Heart Failure
• Dangers of Avandia®
• Avandia® Diabetes
• Avandia® Recall
• Avandia® Side Effects
• Avandia® Information
• Avandia® Attorneys
• Avandia® Lawyers
• Avandia® Lawsuit
• Avandia® Class Action Lawsuits
• Avandia® Litigations
• Avandia® Settlements
• Avandia® Overdose
• Avandia® & Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

A 2007 study revealed that Avandia (generic name: rosiglitazone ) substantially increases a risk of heart attack among users. Since the study came out, there has been much controversy over the type-2 diabetes drug.

Patients who have any history of the following medical conditions should not take Avandia as they are more likely to suffer from heart failure:

• Heart attack or stroke
• Congestive heart failure
• Heart disease
• Liver disease
• Eye problems caused by Diabetes

Avandia Heart Attack Study

An analysis of over 40 Avandia studies published online in The New England Journal of Medicine (NEJM) indicated that as a treatment for diabetes, Avandia is associated with a significantly high risk of heart attack and heart-related death . The study results prompted the U.S. Food and Drug Administration (FDA) to release a safety alert on May 21, 2007, advising those taking Avandia to consider whether other treatment would be appropriate.

If you or a loved one has suffered an Avandia heart attack, it is important to understand that you have certain legal rights. To learn more about the legal remedies available to you, please contact us today.

Studies Reveal Avandia Heart Risks

The 44 studies included in the analysis showed that patients who were treated with Avandia had a 37% higher risk of heart attack and heart-related problems (including death due to a cardiac event) compared to the patients who were given a different diabetes drug or a placebo. Nearly 28,000 patients were involved in the various studies. Patients with a history of heart disease, congestive heart failure, or at risk of heart attack seemed to face the greatest risk.

The primary author of the meta-analysis, Dr. Steven Nissen, first noted Avandia's increased heart risks in an earlier 5,000-patient study sponsored by the drug's manufacturer, the pharmaceutical giant GlaxoSmithKline. That study, called the DREAM trials, was conducted by Glaxo to see whether Avandia could be used to prevent diabetes in addition to its approved use as a diabetes treatment.

The DREAM results showed that, compared to patients taking a placebo, patients taking Avandia had the following:

• 66% more heart attacks
• 39% more strokes
• 20% more deaths from heart-related problems

Avandia Heart Attack & Your Rights

Drug companies like Glaxo have an obligation to adequately test their drugs before bringing them to the market. However, numerous post-marketing studies and reports have raised concerns about Avandia heart risks such as heart attack and even death.

Individuals who have suffered an Avandia heart attack may be eligible to hold Glaxo responsible for their damages by filing an Avandia® lawsuit. To arrange a no cost, no-obligation consultation with an experienced product liability attorney, please contact us today.

"FDA Announces Avandia® Label Change"

The FDA announced that is has made a change regarding cardiovascular risks to the Avandia® (rosiglitazone) label and patient Medication Guide, Feb. 4, 2011.

The FDA announcement also said that Avandia®'s drug label was updated ...

» Read More

"Risk of Death Halts Government Study"

A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.

The 10,000 patient trial was examining the effectiveness of aggressive ...

» Read More

"Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avan"

A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.

Ob...

» Read More